MiR-1290 Contributes to Colorectal Cancer Cell Proliferation by Targeting INPP4B

Overview

Journal Oncol Res

Specialty Oncology

Date 2017 Sep 17

PMID 28915933

Citations 25

Authors

Qingzhu Ma

Yan Wang

Hualing Zhang

Fengqiang Wang

Affiliations

Soon will be listed here.

Abstract

Colorectal cancer (CRC) is one of the most common oncological conditions worldwide, to date. MicroRNA-1290 (miR-1290) has been demonstrated to regulate its progression. We studied the role of miR-1290 in CRC progression. The gene was upregulated in CRC tissues and cells. Its overexpression promoted CRC cell proliferation analyzed by MTT assay, colony formation assay, and soft agar growth assay. In addition, miR-1290 knockdown inhibited CRC cell proliferation. We also found that miR-1290 overexpression reduced the p27 level and increased cyclin D1 at both the mRNA and protein levels, whereas miR-1290 knockdown increased p27 and reduced cyclin D1, confirming miR-1290 promoted CRC cell proliferation. Inositol polyphosphate 4-phosphatase B (INPP4B) was the target of miR-1290. Luciferase reporter assay revealed that miR-1290 directly bound to the 3'-UTR of INPP4B; the mutated seed sites in miR-1290 abrogated this effect. Double knockdown of INPP4B and miR-1290 promoted CRC cell proliferation, suggesting miR-1290 promoted CRC cell proliferation by targeting INPP4B.

Citing Articles

The miR-1290/OGN axis in ovarian cancer-associated fibroblasts modulates cancer cell proliferation and invasion.

Jiang B, Xiao S, Zhang S, Xiao F J Ovarian Res. 2024; 17(1):52.

PMID: 38402185 PMC: 10893657. DOI: 10.1186/s13048-024-01364-w.

Role of inositol polyphosphate-4-phosphatase type II in oncogenesis of digestive system tumors.

Han L, Chen S, Du S World J Gastrointest Oncol. 2023; 15(10):1706-1716.

PMID: 37969410 PMC: 10631434. DOI: 10.4251/wjgo.v15.i10.1706.

Circulating liver cancer stem cells and their stemness-associated MicroRNAs as diagnostic and prognostic biomarkers for viral hepatitis-induced liver cirrhosis and hepatocellular carcinoma.

Hassan M, Nasr S, Amin N, El-Ahwany E, Zoheiry M, ElZallat M Noncoding RNA Res. 2023; 8(2):155-163.

PMID: 36632614 PMC: 9826835. DOI: 10.1016/j.ncrna.2022.12.006.

Hsa_circ_0026344 suppresses gastric cancer progression via modulating the miR-1290/FBP2 axis.

Xiao G, Zhang T, Tan B, Hao H Histol Histopathol. 2022; 38(9):1017-1028.

PMID: 36515277 DOI: 10.14670/HH-18-564.

Cancer associated fibroblasts secreted exosomal miR-1290 contributes to prostate cancer cell growth and metastasis via targeting GSK3β.

Wang S, Du P, Cao Y, Ma J, Yang X, Yu Z Cell Death Discov. 2022; 8(1):371.

PMID: 35999213 PMC: 9399109. DOI: 10.1038/s41420-022-01163-6.

References

Mao Y, Liu J, Zhang D, Li B . MiR-1290 promotes cancer progression by targeting nuclear factor I/X(NFIX) in esophageal squamous cell carcinoma (ESCC). Biomed Pharmacother. 2015; 76:82-93. DOI: 10.1016/j.biopha.2015.10.005. View

Balaguer F, Moreira L, Lozano J, Link A, Ramirez G, Shen Y . Colorectal cancers with microsatellite instability display unique miRNA profiles. Clin Cancer Res. 2011; 17(19):6239-49. PMC: 3186834. DOI: 10.1158/1078-0432.CCR-11-1424. View

Vo T, Fruman D . INPP4B Is a Tumor Suppressor in the Context of PTEN Deficiency. Cancer Discov. 2015; 5(7):697-700. PMC: 4499858. DOI: 10.1158/2159-8290.CD-15-0609. View

Sun B, Yang N, Jiang Y, Zhang H, Hou C, Ji C . Antagomir-1290 suppresses CD133⁺ cells in non-small cell lung cancer by targeting fyn-related Src family tyrosine kinase. Tumour Biol. 2015; 36(8):6223-30. DOI: 10.1007/s13277-015-3307-4. View

Kim G, An H, Lee M, Song J, Jeong J, Lee J . Hsa-miR-1246 and hsa-miR-1290 are associated with stemness and invasiveness of non-small cell lung cancer. Lung Cancer. 2015; 91:15-22. DOI: 10.1016/j.lungcan.2015.11.013. View

Li A, Yu J, Kim H, Wolfgang C, Canto M, Hruban R . MicroRNA array analysis finds elevated serum miR-1290 accurately distinguishes patients with low-stage pancreatic cancer from healthy and disease controls. Clin Cancer Res. 2013; 19(13):3600-10. PMC: 3707520. DOI: 10.1158/1078-0432.CCR-12-3092. View

Sun Y, Ding H, Liu X, Li X, Li L . INPP4B overexpression enhances the antitumor efficacy of PARP inhibitor AG014699 in MDA-MB-231 triple-negative breast cancer cells. Tumour Biol. 2014; 35(5):4469-77. DOI: 10.1007/s13277-013-1589-y. View

Huang X, Yuan T, Liang M, Du M, Xia S, Dittmar R . Exosomal miR-1290 and miR-375 as prognostic markers in castration-resistant prostate cancer. Eur Urol. 2014; 67(1):33-41. PMC: 4252606. DOI: 10.1016/j.eururo.2014.07.035. View

Hodgson M, Shao L, Frolov A, Li R, Peterson L, Ayala G . Decreased expression and androgen regulation of the tumor suppressor gene INPP4B in prostate cancer. Cancer Res. 2011; 71(2):572-82. PMC: 3077543. DOI: 10.1158/0008-5472.CAN-10-2314. View

10.

Torre L, Bray F, Siegel R, Ferlay J, Lortet-Tieulent J, Jemal A . Global cancer statistics, 2012. CA Cancer J Clin. 2015; 65(2):87-108. DOI: 10.3322/caac.21262. View

11.

Rynkiewicz N, Fedele C, Chiam K, Gupta R, Kench J, Ooms L . INPP4B is highly expressed in prostate intermediate cells and its loss of expression in prostate carcinoma predicts for recurrence and poor long term survival. Prostate. 2014; 75(1):92-102. DOI: 10.1002/pros.22895. View

12.

Guo S, Chi M, Yang R, Guo X, Zan L, Wang C . INPP4B is an oncogenic regulator in human colon cancer. Oncogene. 2015; 35(23):3049-61. PMC: 4908438. DOI: 10.1038/onc.2015.361. View

13.

Agarwal R . Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents. Biochem Pharmacol. 2000; 60(8):1051-9. DOI: 10.1016/s0006-2952(00)00385-3. View

14.

Hsu I, Yeh C, Slavin S, Miyamoto H, Netto G, Tsai Y . Estrogen receptor alpha prevents bladder cancer via INPP4B inhibited akt pathway in vitro and in vivo. Oncotarget. 2014; 5(17):7917-35. PMC: 4202170. DOI: 10.18632/oncotarget.1421. View

15.

Gasser J, Inuzuka H, Lau A, Wei W, Beroukhim R, Toker A . SGK3 mediates INPP4B-dependent PI3K signaling in breast cancer. Mol Cell. 2014; 56(4):595-607. PMC: 4255362. DOI: 10.1016/j.molcel.2014.09.023. View

16.

Li M, He X, Zhang Z, Li S, Ren L, Cao R . MicroRNA-1290 promotes esophageal squamous cell carcinoma cell proliferation and metastasis. World J Gastroenterol. 2015; 21(11):3245-55. PMC: 4363754. DOI: 10.3748/wjg.v21.i11.3245. View

17.

Valeri N, Braconi C, Gasparini P, Murgia C, Lampis A, Paulus-Hock V . MicroRNA-135b promotes cancer progression by acting as a downstream effector of oncogenic pathways in colon cancer. Cancer Cell. 2014; 25(4):469-83. PMC: 3995091. DOI: 10.1016/j.ccr.2014.03.006. View

18.

Fedele C, Ooms L, Ho M, Vieusseux J, OToole S, Millar E . Inositol polyphosphate 4-phosphatase II regulates PI3K/Akt signaling and is lost in human basal-like breast cancers. Proc Natl Acad Sci U S A. 2010; 107(51):22231-6. PMC: 3009830. DOI: 10.1073/pnas.1015245107. View

19.

Perez-Lorenzo R, Gill K, Shen C, Zhao F, Zheng B, Schulze H . A tumor suppressor function for the lipid phosphatase INPP4B in melanocytic neoplasms. J Invest Dermatol. 2013; 134(5):1359-1368. DOI: 10.1038/jid.2013.511. View

20.

Mo D, Gu B, Gong X, Wu L, Wang H, Jiang Y . miR-1290 is a potential prognostic biomarker in non-small cell lung cancer. J Thorac Dis. 2015; 7(9):1570-9. PMC: 4598517. DOI: 10.3978/j.issn.2072-1439.2015.09.38. View